Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.

Haematologica - 1 Feb 2015

Laverdière Isabelle, Guillemette Chantal, Tamouza Ryad, Loiseau Pascale, Peffault de Latour Regis, Robin Marie, Couture Félix, Filion Alain, Lalancette Marc, Tourancheau Alan, Charron Dominique, Socié Gérard, Lévesque Éric

Abstract excerpt

Effective immunosuppression is mandatory to prevent graft-versus-host disease and to achieve a successful clinical outcome of hematopoietic stem cell transplantation. Here we tested whether germline single nucleotide polymorphisms in 20 candidate genes related to methotrexate and cyclosporine met...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Canada
Share to Chronic Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclosporine

Share to Graft vs Host Disease

Share to Hematologic Neoplasms

Share to Immunosuppressive Agents

Share to Methotrexate

Source

Open in PubMed Open full text

Identifiers

PMID: 25425682
DOI: 10.3324/haematol.2014.109884
PMCID: PMC4803136

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25425682-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.PMID 25425682Read ↗

Post-transplant complications revealed by mycophenolate mofetil related transporters and metabolic enzymes gene polymorphisms in pediatric patients with hematological disorders.Semantic proximity Read ↗

Genetic variations in the mycophenolate mofetil target enzyme are associated with acute GVHD risk after related and unrelated hematopoietic cell transplantation.Semantic proximity Read ↗

Effects of cyclophosphamide related genetic variants on clinical outcomes of adult hematopoietic cell transplant patientsSemantic proximity Read ↗

Associations between polymorphisms in target, metabolism, or transport proteins of mycophenolate sodium and therapeutic or adverse effects in kidney transplant patients.Semantic proximity Read ↗

Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping reviewSemantic proximity Read ↗

IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients.Semantic proximity Read ↗

SNPs affecting the clinical outcomes of regularly used immunosuppressants.Semantic proximity Read ↗

Variants in mycophenolate and CMV antiviral drug pharmacokinetic and pharmacodynamic genes and leukopenia in heart transplant recipients.Semantic proximity Read ↗

The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis.Semantic proximity Read ↗

Severity and organ distribution of graft-versus-host disease with post-transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA-matched or single-allele mismatched stem cell transplantation.Semantic proximity Read ↗

Genetic prediction of renal transplant outcomeSemantic proximity Read ↗

Genomic Strategies in Transplantation "The Right Drug for the Right Patient".Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.